T. Baker

Detection of redundant fusion transcripts as biomarkers or disease-specific therapeutic targets in breast cancer.

Krishna R. Kalari, Jennifer M. Carr, G. Schroth, 2012, Cancer research.

Deep Sequence Analysis of Non-Small Cell Lung Cancer: Integrated Analysis of Gene Expression, Alternative Splicing, and Single Nucleotide Variations in Lung Adenocarcinomas with and without Oncogenic KRAS Mutations

Krishna R. Kalari, Jennifer M. Carr, Asha A. Nair, 2012, Front. Oncol..

Integrated Analysis of Gene Expression, CpG Island Methylation, and Gene Copy Number in Breast Cancer Cells by Deep Sequencing

Krishna R. Kalari, Brian Bot, Jeanette E. Eckel-Passow, 2011, PloS one.

Impact of Library Preparation on Downstream Analysis and Interpretation of RNA-Seq Data: Comparison between Illumina PolyA and NuGEN Ovation Protocol

Krishna R. Kalari, Jean-Pierre A. Kocher, Asha Nair, 2013, PloS one.

An Integrated Model of the Transcriptome of HER2-Positive Breast Cancer

Saurabh Baheti, Krishna R. Kalari, Kevin J. Thompson, 2013, PloS one.

Distinct E-cadherin-based complexes regulate cell behaviour through miRNA processing or Src and p120 catenin activity

Jennifer M. Carr, T. Baker, J. Carr, 2015, Nature Cell Biology.

Disease-Specific Therapeutic Targets in Breast Cancer Detection of Redundant Fusion Transcripts as Biomarkers or

Krishna R. Kalari, Jennifer M. Carr, G. Schroth, 2012 .